PepTimer
Open in PepTimer

← Library

Mazdutide

Also known as IBI362, LY3305677

A weekly weight-loss injection approved in China in 2025. It acts on both GLP-1 and glucagon.

Quick facts

Status
Not an approved medicine
Evidence
Approved in China (phase 3 trials)
Taken as
Injection under the skin once a week
Common sizes
5 mg, 10 mg
Category
GLP-1/glucagon receptor agonist · weight

How it works

The GLP-1 part reduces hunger and helps blood sugar. The glucagon part may raise how much energy your body burns and reduce liver fat.

What people use it for

  • Weight loss (approved in China)
  • Type 2 diabetes (studied in China)

What the research shows

  • Phase 3 trials in China showed meaningful weight loss.
  • Not studied or approved in the EU or US.

Side effects & risks

  • Nausea, diarrhoea and vomiting, mostly at the start
  • Faster heart rate
  • Products sold online outside China are unregulated

Is it legal?

Approved by China's NMPA (June 2025) for chronic weight management. Not approved in the EU, UK or US.

Storage & safe handling

  • Mix with bacteriostatic water: let it run slowly down the inside of the vial and swirl gently — never shake.
  • Store the mixed vial in the fridge and follow the use-by period on the label.
  • Wipe the vial top with alcohol and use a new sterile needle and syringe every time.
  • Rotate injection sites so the same spot is not used again and again.
  • Put used needles in a sharps container, not the household bin.
  • Get medical help for redness that spreads, fever, swelling or trouble breathing.
Open in PepTimerTrack your protocol, calculate how much to draw and get reminders — free.Open in PepTimer
Sources: Innovent announcement of NMPA approval (June 2025); GLORY-1 phase 3 trial.
Last updated 12 October 2026. Information — not medical advice. PepTimer does not replace a doctor. Many peptides are not approved medicines in the EU, UK or US. Talk to a qualified healthcare provider before starting, changing or stopping any treatment.